nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—migraine—Prednisone—asthma	0.416	1	CpDpCtD
Dihydroergotamine—ABCB1—Fluticasone furoate—asthma	0.0289	0.0883	CbGbCtD
Dihydroergotamine—ABCB1—Indacaterol—asthma	0.0236	0.072	CbGbCtD
Dihydroergotamine—CYP3A4—Fluticasone furoate—asthma	0.0173	0.0529	CbGbCtD
Dihydroergotamine—CYP3A4—Budesonide—asthma	0.0155	0.0472	CbGbCtD
Dihydroergotamine—CYP3A4—Ciclesonide—asthma	0.0141	0.0431	CbGbCtD
Dihydroergotamine—CYP3A4—Indacaterol—asthma	0.0141	0.0431	CbGbCtD
Dihydroergotamine—CYP3A4—Salmeterol—asthma	0.0131	0.0401	CbGbCtD
Dihydroergotamine—CYP3A4—Flunisolide—asthma	0.0131	0.0401	CbGbCtD
Dihydroergotamine—CYP3A4—Salbutamol—asthma	0.0131	0.0401	CbGbCtD
Dihydroergotamine—ABCB1—Loratadine—asthma	0.0126	0.0384	CbGbCtD
Dihydroergotamine—CYP3A4—Zileuton—asthma	0.0117	0.0357	CbGbCtD
Dihydroergotamine—CYP3A4—Ipratropium bromide—asthma	0.0117	0.0357	CbGbCtD
Dihydroergotamine—ABCB1—Methylprednisolone—asthma	0.0115	0.0352	CbGbCtD
Dihydroergotamine—CYP3A4—Fluticasone Propionate—asthma	0.0112	0.0341	CbGbCtD
Dihydroergotamine—CYP3A4—Zafirlukast—asthma	0.0103	0.0315	CbGbCtD
Dihydroergotamine—CYP3A4—Tiotropium—asthma	0.00888	0.0271	CbGbCtD
Dihydroergotamine—CYP3A4—Aminophylline—asthma	0.00847	0.0258	CbGbCtD
Dihydroergotamine—CYP3A4—Theophylline—asthma	0.00796	0.0243	CbGbCtD
Dihydroergotamine—CYP3A4—Montelukast—asthma	0.00755	0.023	CbGbCtD
Dihydroergotamine—CYP3A4—Loratadine—asthma	0.00755	0.023	CbGbCtD
Dihydroergotamine—ABCB1—Betamethasone—asthma	0.00749	0.0229	CbGbCtD
Dihydroergotamine—ABCB1—Prednisolone—asthma	0.00739	0.0226	CbGbCtD
Dihydroergotamine—ABCB1—Hydrocortisone—asthma	0.00701	0.0214	CbGbCtD
Dihydroergotamine—ABCB1—Prednisone—asthma	0.00698	0.0213	CbGbCtD
Dihydroergotamine—CYP3A4—Methylprednisolone—asthma	0.00691	0.0211	CbGbCtD
Dihydroergotamine—CYP3A4—Triamcinolone—asthma	0.00523	0.016	CbGbCtD
Dihydroergotamine—CYP3A4—Betamethasone—asthma	0.00449	0.0137	CbGbCtD
Dihydroergotamine—CYP3A4—Prednisolone—asthma	0.00443	0.0135	CbGbCtD
Dihydroergotamine—ABCB1—Dexamethasone—asthma	0.00436	0.0133	CbGbCtD
Dihydroergotamine—CYP3A4—Hydrocortisone—asthma	0.0042	0.0128	CbGbCtD
Dihydroergotamine—CYP3A4—Prednisone—asthma	0.00418	0.0128	CbGbCtD
Dihydroergotamine—CYP3A4—Dexamethasone—asthma	0.00261	0.00797	CbGbCtD
Dihydroergotamine—Rash—Formoterol—asthma	5.57e-05	0.000315	CcSEcCtD
Dihydroergotamine—Dermatitis—Formoterol—asthma	5.57e-05	0.000315	CcSEcCtD
Dihydroergotamine—Dermatitis—Arformoterol—asthma	5.57e-05	0.000315	CcSEcCtD
Dihydroergotamine—Headache—Arformoterol—asthma	5.54e-05	0.000313	CcSEcCtD
Dihydroergotamine—Headache—Formoterol—asthma	5.54e-05	0.000313	CcSEcCtD
Dihydroergotamine—Diarrhoea—Budesonide—asthma	5.53e-05	0.000313	CcSEcCtD
Dihydroergotamine—Dizziness—Salbutamol—asthma	5.52e-05	0.000312	CcSEcCtD
Dihydroergotamine—Vomiting—Montelukast—asthma	5.5e-05	0.000312	CcSEcCtD
Dihydroergotamine—Rash—Montelukast—asthma	5.46e-05	0.000309	CcSEcCtD
Dihydroergotamine—Dermatitis—Montelukast—asthma	5.45e-05	0.000309	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Prednisolone—asthma	5.44e-05	0.000308	CcSEcCtD
Dihydroergotamine—Headache—Montelukast—asthma	5.42e-05	0.000307	CcSEcCtD
Dihydroergotamine—Visual impairment—Betamethasone—asthma	5.42e-05	0.000307	CcSEcCtD
Dihydroergotamine—Visual impairment—Dexamethasone—asthma	5.42e-05	0.000307	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Prednisone—asthma	5.38e-05	0.000304	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Prednisone—asthma	5.35e-05	0.000303	CcSEcCtD
Dihydroergotamine—Dizziness—Budesonide—asthma	5.35e-05	0.000303	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Hydrocortisone—asthma	5.32e-05	0.000301	CcSEcCtD
Dihydroergotamine—Vomiting—Salbutamol—asthma	5.31e-05	0.0003	CcSEcCtD
Dihydroergotamine—Malaise—Prednisolone—asthma	5.29e-05	0.000299	CcSEcCtD
Dihydroergotamine—Vertigo—Prednisolone—asthma	5.27e-05	0.000298	CcSEcCtD
Dihydroergotamine—Rash—Salbutamol—asthma	5.26e-05	0.000298	CcSEcCtD
Dihydroergotamine—Dermatitis—Salbutamol—asthma	5.26e-05	0.000298	CcSEcCtD
Dihydroergotamine—Nausea—Arformoterol—asthma	5.25e-05	0.000297	CcSEcCtD
Dihydroergotamine—Nausea—Formoterol—asthma	5.25e-05	0.000297	CcSEcCtD
Dihydroergotamine—Headache—Salbutamol—asthma	5.23e-05	0.000296	CcSEcCtD
Dihydroergotamine—Malaise—Hydrocortisone—asthma	5.17e-05	0.000292	CcSEcCtD
Dihydroergotamine—Vertigo—Hydrocortisone—asthma	5.15e-05	0.000291	CcSEcCtD
Dihydroergotamine—Nausea—Montelukast—asthma	5.14e-05	0.000291	CcSEcCtD
Dihydroergotamine—Vomiting—Budesonide—asthma	5.14e-05	0.000291	CcSEcCtD
Dihydroergotamine—Rash—Budesonide—asthma	5.1e-05	0.000288	CcSEcCtD
Dihydroergotamine—Dermatitis—Budesonide—asthma	5.09e-05	0.000288	CcSEcCtD
Dihydroergotamine—Headache—Budesonide—asthma	5.06e-05	0.000287	CcSEcCtD
Dihydroergotamine—Hypertension—Prednisolone—asthma	5.06e-05	0.000287	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Triamcinolone—asthma	5e-05	0.000283	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Methylprednisolone—asthma	4.99e-05	0.000283	CcSEcCtD
Dihydroergotamine—Nausea—Salbutamol—asthma	4.96e-05	0.000281	CcSEcCtD
Dihydroergotamine—Hypertension—Hydrocortisone—asthma	4.95e-05	0.00028	CcSEcCtD
Dihydroergotamine—Discomfort—Prednisolone—asthma	4.93e-05	0.000279	CcSEcCtD
Dihydroergotamine—Myalgia—Hydrocortisone—asthma	4.88e-05	0.000276	CcSEcCtD
Dihydroergotamine—Malaise—Triamcinolone—asthma	4.86e-05	0.000275	CcSEcCtD
Dihydroergotamine—Anxiety—Hydrocortisone—asthma	4.86e-05	0.000275	CcSEcCtD
Dihydroergotamine—Malaise—Methylprednisolone—asthma	4.85e-05	0.000275	CcSEcCtD
Dihydroergotamine—Vertigo—Triamcinolone—asthma	4.85e-05	0.000274	CcSEcCtD
Dihydroergotamine—Vertigo—Methylprednisolone—asthma	4.84e-05	0.000274	CcSEcCtD
Dihydroergotamine—Discomfort—Hydrocortisone—asthma	4.82e-05	0.000273	CcSEcCtD
Dihydroergotamine—Nausea—Budesonide—asthma	4.8e-05	0.000272	CcSEcCtD
Dihydroergotamine—Oedema—Prednisolone—asthma	4.79e-05	0.000271	CcSEcCtD
Dihydroergotamine—Shock—Prednisolone—asthma	4.71e-05	0.000267	CcSEcCtD
Dihydroergotamine—Oedema—Hydrocortisone—asthma	4.68e-05	0.000265	CcSEcCtD
Dihydroergotamine—Tachycardia—Prednisolone—asthma	4.67e-05	0.000264	CcSEcCtD
Dihydroergotamine—Hypertension—Triamcinolone—asthma	4.66e-05	0.000264	CcSEcCtD
Dihydroergotamine—Hypertension—Methylprednisolone—asthma	4.65e-05	0.000263	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Prednisolone—asthma	4.63e-05	0.000262	CcSEcCtD
Dihydroergotamine—Shock—Hydrocortisone—asthma	4.6e-05	0.00026	CcSEcCtD
Dihydroergotamine—Myalgia—Triamcinolone—asthma	4.59e-05	0.00026	CcSEcCtD
Dihydroergotamine—Arthralgia—Methylprednisolone—asthma	4.58e-05	0.000259	CcSEcCtD
Dihydroergotamine—Myalgia—Methylprednisolone—asthma	4.58e-05	0.000259	CcSEcCtD
Dihydroergotamine—Anxiety—Methylprednisolone—asthma	4.57e-05	0.000258	CcSEcCtD
Dihydroergotamine—Tachycardia—Hydrocortisone—asthma	4.56e-05	0.000258	CcSEcCtD
Dihydroergotamine—Flushing—Prednisone—asthma	4.54e-05	0.000257	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Dexamethasone—asthma	4.54e-05	0.000257	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Betamethasone—asthma	4.54e-05	0.000257	CcSEcCtD
Dihydroergotamine—Discomfort—Triamcinolone—asthma	4.54e-05	0.000257	CcSEcCtD
Dihydroergotamine—Discomfort—Methylprednisolone—asthma	4.53e-05	0.000256	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Hydrocortisone—asthma	4.52e-05	0.000256	CcSEcCtD
Dihydroergotamine—Dry mouth—Triamcinolone—asthma	4.49e-05	0.000254	CcSEcCtD
Dihydroergotamine—Anorexia—Hydrocortisone—asthma	4.46e-05	0.000252	CcSEcCtD
Dihydroergotamine—Confusional state—Methylprednisolone—asthma	4.43e-05	0.000251	CcSEcCtD
Dihydroergotamine—Malaise—Betamethasone—asthma	4.41e-05	0.00025	CcSEcCtD
Dihydroergotamine—Malaise—Dexamethasone—asthma	4.41e-05	0.00025	CcSEcCtD
Dihydroergotamine—Oedema—Triamcinolone—asthma	4.4e-05	0.000249	CcSEcCtD
Dihydroergotamine—Vertigo—Dexamethasone—asthma	4.4e-05	0.000249	CcSEcCtD
Dihydroergotamine—Vertigo—Betamethasone—asthma	4.4e-05	0.000249	CcSEcCtD
Dihydroergotamine—Hypotension—Hydrocortisone—asthma	4.37e-05	0.000247	CcSEcCtD
Dihydroergotamine—Shock—Triamcinolone—asthma	4.33e-05	0.000245	CcSEcCtD
Dihydroergotamine—Insomnia—Prednisolone—asthma	4.33e-05	0.000245	CcSEcCtD
Dihydroergotamine—Shock—Methylprednisolone—asthma	4.32e-05	0.000245	CcSEcCtD
Dihydroergotamine—Paraesthesia—Prednisolone—asthma	4.3e-05	0.000243	CcSEcCtD
Dihydroergotamine—Tachycardia—Triamcinolone—asthma	4.3e-05	0.000243	CcSEcCtD
Dihydroergotamine—Tachycardia—Methylprednisolone—asthma	4.29e-05	0.000243	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Hydrocortisone—asthma	4.26e-05	0.000241	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Triamcinolone—asthma	4.26e-05	0.000241	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Methylprednisolone—asthma	4.25e-05	0.00024	CcSEcCtD
Dihydroergotamine—Insomnia—Hydrocortisone—asthma	4.23e-05	0.000239	CcSEcCtD
Dihydroergotamine—Hypertension—Dexamethasone—asthma	4.23e-05	0.000239	CcSEcCtD
Dihydroergotamine—Hypertension—Betamethasone—asthma	4.23e-05	0.000239	CcSEcCtD
Dihydroergotamine—Paraesthesia—Hydrocortisone—asthma	4.2e-05	0.000238	CcSEcCtD
Dihydroergotamine—Myalgia—Dexamethasone—asthma	4.17e-05	0.000236	CcSEcCtD
Dihydroergotamine—Myalgia—Betamethasone—asthma	4.17e-05	0.000236	CcSEcCtD
Dihydroergotamine—Anxiety—Betamethasone—asthma	4.15e-05	0.000235	CcSEcCtD
Dihydroergotamine—Anxiety—Dexamethasone—asthma	4.15e-05	0.000235	CcSEcCtD
Dihydroergotamine—Discomfort—Betamethasone—asthma	4.12e-05	0.000233	CcSEcCtD
Dihydroergotamine—Discomfort—Dexamethasone—asthma	4.12e-05	0.000233	CcSEcCtD
Dihydroergotamine—Dyspepsia—Hydrocortisone—asthma	4.12e-05	0.000233	CcSEcCtD
Dihydroergotamine—Hypotension—Methylprednisolone—asthma	4.1e-05	0.000232	CcSEcCtD
Dihydroergotamine—Pain—Prednisolone—asthma	4.09e-05	0.000232	CcSEcCtD
Dihydroergotamine—Decreased appetite—Hydrocortisone—asthma	4.06e-05	0.00023	CcSEcCtD
Dihydroergotamine—Fatigue—Hydrocortisone—asthma	4.03e-05	0.000228	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Triamcinolone—asthma	4.01e-05	0.000227	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Methylprednisolone—asthma	4e-05	0.000226	CcSEcCtD
Dihydroergotamine—Pain—Hydrocortisone—asthma	4e-05	0.000226	CcSEcCtD
Dihydroergotamine—Oedema—Dexamethasone—asthma	3.99e-05	0.000226	CcSEcCtD
Dihydroergotamine—Oedema—Betamethasone—asthma	3.99e-05	0.000226	CcSEcCtD
Dihydroergotamine—Insomnia—Triamcinolone—asthma	3.98e-05	0.000225	CcSEcCtD
Dihydroergotamine—Insomnia—Methylprednisolone—asthma	3.97e-05	0.000225	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Prednisone—asthma	3.95e-05	0.000224	CcSEcCtD
Dihydroergotamine—Paraesthesia—Triamcinolone—asthma	3.95e-05	0.000224	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Prednisolone—asthma	3.94e-05	0.000223	CcSEcCtD
Dihydroergotamine—Paraesthesia—Methylprednisolone—asthma	3.94e-05	0.000223	CcSEcCtD
Dihydroergotamine—Shock—Dexamethasone—asthma	3.93e-05	0.000222	CcSEcCtD
Dihydroergotamine—Shock—Betamethasone—asthma	3.93e-05	0.000222	CcSEcCtD
Dihydroergotamine—Dyspnoea—Triamcinolone—asthma	3.92e-05	0.000222	CcSEcCtD
Dihydroergotamine—Agitation—Prednisone—asthma	3.92e-05	0.000222	CcSEcCtD
Dihydroergotamine—Tachycardia—Betamethasone—asthma	3.9e-05	0.000221	CcSEcCtD
Dihydroergotamine—Tachycardia—Dexamethasone—asthma	3.9e-05	0.000221	CcSEcCtD
Dihydroergotamine—Dyspepsia—Triamcinolone—asthma	3.88e-05	0.000219	CcSEcCtD
Dihydroergotamine—Dyspepsia—Methylprednisolone—asthma	3.87e-05	0.000219	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Dexamethasone—asthma	3.86e-05	0.000219	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Betamethasone—asthma	3.86e-05	0.000219	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Hydrocortisone—asthma	3.85e-05	0.000218	CcSEcCtD
Dihydroergotamine—Malaise—Prednisone—asthma	3.84e-05	0.000218	CcSEcCtD
Dihydroergotamine—Vertigo—Prednisone—asthma	3.83e-05	0.000217	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Hydrocortisone—asthma	3.82e-05	0.000216	CcSEcCtD
Dihydroergotamine—Anorexia—Betamethasone—asthma	3.81e-05	0.000215	CcSEcCtD
Dihydroergotamine—Anorexia—Dexamethasone—asthma	3.81e-05	0.000215	CcSEcCtD
Dihydroergotamine—Urticaria—Prednisolone—asthma	3.8e-05	0.000215	CcSEcCtD
Dihydroergotamine—Fatigue—Triamcinolone—asthma	3.8e-05	0.000215	CcSEcCtD
Dihydroergotamine—Fatigue—Methylprednisolone—asthma	3.79e-05	0.000214	CcSEcCtD
Dihydroergotamine—Pain—Triamcinolone—asthma	3.76e-05	0.000213	CcSEcCtD
Dihydroergotamine—Hypotension—Dexamethasone—asthma	3.73e-05	0.000211	CcSEcCtD
Dihydroergotamine—Hypotension—Betamethasone—asthma	3.73e-05	0.000211	CcSEcCtD
Dihydroergotamine—Urticaria—Hydrocortisone—asthma	3.71e-05	0.00021	CcSEcCtD
Dihydroergotamine—Body temperature increased—Hydrocortisone—asthma	3.7e-05	0.000209	CcSEcCtD
Dihydroergotamine—Abdominal pain—Hydrocortisone—asthma	3.7e-05	0.000209	CcSEcCtD
Dihydroergotamine—Hypertension—Prednisone—asthma	3.68e-05	0.000208	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Dexamethasone—asthma	3.64e-05	0.000206	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Betamethasone—asthma	3.64e-05	0.000206	CcSEcCtD
Dihydroergotamine—Arthralgia—Prednisone—asthma	3.63e-05	0.000205	CcSEcCtD
Dihydroergotamine—Myalgia—Prednisone—asthma	3.63e-05	0.000205	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Triamcinolone—asthma	3.63e-05	0.000205	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Methylprednisolone—asthma	3.62e-05	0.000205	CcSEcCtD
Dihydroergotamine—Anxiety—Prednisone—asthma	3.62e-05	0.000205	CcSEcCtD
Dihydroergotamine—Insomnia—Dexamethasone—asthma	3.61e-05	0.000204	CcSEcCtD
Dihydroergotamine—Insomnia—Betamethasone—asthma	3.61e-05	0.000204	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Methylprednisolone—asthma	3.59e-05	0.000203	CcSEcCtD
Dihydroergotamine—Paraesthesia—Dexamethasone—asthma	3.59e-05	0.000203	CcSEcCtD
Dihydroergotamine—Paraesthesia—Betamethasone—asthma	3.59e-05	0.000203	CcSEcCtD
Dihydroergotamine—Discomfort—Prednisone—asthma	3.59e-05	0.000203	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Prednisolone—asthma	3.53e-05	0.0002	CcSEcCtD
Dihydroergotamine—Dyspepsia—Betamethasone—asthma	3.52e-05	0.000199	CcSEcCtD
Dihydroergotamine—Dyspepsia—Dexamethasone—asthma	3.52e-05	0.000199	CcSEcCtD
Dihydroergotamine—Urticaria—Triamcinolone—asthma	3.5e-05	0.000198	CcSEcCtD
Dihydroergotamine—Urticaria—Methylprednisolone—asthma	3.49e-05	0.000197	CcSEcCtD
Dihydroergotamine—Body temperature increased—Triamcinolone—asthma	3.48e-05	0.000197	CcSEcCtD
Dihydroergotamine—Oedema—Prednisone—asthma	3.48e-05	0.000197	CcSEcCtD
Dihydroergotamine—Abdominal pain—Methylprednisolone—asthma	3.47e-05	0.000197	CcSEcCtD
Dihydroergotamine—Decreased appetite—Betamethasone—asthma	3.47e-05	0.000197	CcSEcCtD
Dihydroergotamine—Decreased appetite—Dexamethasone—asthma	3.47e-05	0.000197	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Hydrocortisone—asthma	3.44e-05	0.000195	CcSEcCtD
Dihydroergotamine—Fatigue—Betamethasone—asthma	3.44e-05	0.000195	CcSEcCtD
Dihydroergotamine—Fatigue—Dexamethasone—asthma	3.44e-05	0.000195	CcSEcCtD
Dihydroergotamine—Shock—Prednisone—asthma	3.42e-05	0.000194	CcSEcCtD
Dihydroergotamine—Pain—Dexamethasone—asthma	3.42e-05	0.000193	CcSEcCtD
Dihydroergotamine—Pain—Betamethasone—asthma	3.42e-05	0.000193	CcSEcCtD
Dihydroergotamine—Tachycardia—Prednisone—asthma	3.4e-05	0.000192	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Prednisone—asthma	3.36e-05	0.00019	CcSEcCtD
Dihydroergotamine—Asthenia—Hydrocortisone—asthma	3.35e-05	0.00019	CcSEcCtD
Dihydroergotamine—Anorexia—Prednisone—asthma	3.32e-05	0.000188	CcSEcCtD
Dihydroergotamine—Pruritus—Hydrocortisone—asthma	3.31e-05	0.000187	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Betamethasone—asthma	3.29e-05	0.000186	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Dexamethasone—asthma	3.29e-05	0.000186	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Dexamethasone—asthma	3.27e-05	0.000185	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Betamethasone—asthma	3.27e-05	0.000185	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Triamcinolone—asthma	3.24e-05	0.000184	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Methylprednisolone—asthma	3.24e-05	0.000183	CcSEcCtD
Dihydroergotamine—Diarrhoea—Hydrocortisone—asthma	3.2e-05	0.000181	CcSEcCtD
Dihydroergotamine—Urticaria—Betamethasone—asthma	3.17e-05	0.00018	CcSEcCtD
Dihydroergotamine—Urticaria—Dexamethasone—asthma	3.17e-05	0.00018	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Prednisone—asthma	3.17e-05	0.000179	CcSEcCtD
Dihydroergotamine—Dizziness—Prednisolone—asthma	3.17e-05	0.000179	CcSEcCtD
Dihydroergotamine—Asthenia—Triamcinolone—asthma	3.16e-05	0.000179	CcSEcCtD
Dihydroergotamine—Body temperature increased—Dexamethasone—asthma	3.16e-05	0.000179	CcSEcCtD
Dihydroergotamine—Abdominal pain—Betamethasone—asthma	3.16e-05	0.000179	CcSEcCtD
Dihydroergotamine—Abdominal pain—Dexamethasone—asthma	3.16e-05	0.000179	CcSEcCtD
Dihydroergotamine—Body temperature increased—Betamethasone—asthma	3.16e-05	0.000179	CcSEcCtD
Dihydroergotamine—Asthenia—Methylprednisolone—asthma	3.15e-05	0.000178	CcSEcCtD
Dihydroergotamine—Insomnia—Prednisone—asthma	3.15e-05	0.000178	CcSEcCtD
Dihydroergotamine—Paraesthesia—Prednisone—asthma	3.12e-05	0.000177	CcSEcCtD
Dihydroergotamine—Pruritus—Triamcinolone—asthma	3.11e-05	0.000176	CcSEcCtD
Dihydroergotamine—Pruritus—Methylprednisolone—asthma	3.11e-05	0.000176	CcSEcCtD
Dihydroergotamine—Dizziness—Hydrocortisone—asthma	3.09e-05	0.000175	CcSEcCtD
Dihydroergotamine—Dyspepsia—Prednisone—asthma	3.06e-05	0.000173	CcSEcCtD
Dihydroergotamine—Decreased appetite—Prednisone—asthma	3.02e-05	0.000171	CcSEcCtD
Dihydroergotamine—Rash—Prednisolone—asthma	3.02e-05	0.000171	CcSEcCtD
Dihydroergotamine—Dermatitis—Prednisolone—asthma	3.02e-05	0.000171	CcSEcCtD
Dihydroergotamine—Diarrhoea—Methylprednisolone—asthma	3.01e-05	0.00017	CcSEcCtD
Dihydroergotamine—Fatigue—Prednisone—asthma	3e-05	0.00017	CcSEcCtD
Dihydroergotamine—Headache—Prednisolone—asthma	3e-05	0.00017	CcSEcCtD
Dihydroergotamine—Vomiting—Hydrocortisone—asthma	2.97e-05	0.000168	CcSEcCtD
Dihydroergotamine—Rash—Hydrocortisone—asthma	2.95e-05	0.000167	CcSEcCtD
Dihydroergotamine—Dermatitis—Hydrocortisone—asthma	2.95e-05	0.000167	CcSEcCtD
Dihydroergotamine—Headache—Hydrocortisone—asthma	2.93e-05	0.000166	CcSEcCtD
Dihydroergotamine—Dizziness—Triamcinolone—asthma	2.91e-05	0.000165	CcSEcCtD
Dihydroergotamine—Dizziness—Methylprednisolone—asthma	2.9e-05	0.000164	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Prednisone—asthma	2.87e-05	0.000162	CcSEcCtD
Dihydroergotamine—Asthenia—Dexamethasone—asthma	2.87e-05	0.000162	CcSEcCtD
Dihydroergotamine—Asthenia—Betamethasone—asthma	2.87e-05	0.000162	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Prednisone—asthma	2.84e-05	0.000161	CcSEcCtD
Dihydroergotamine—Nausea—Prednisolone—asthma	2.84e-05	0.000161	CcSEcCtD
Dihydroergotamine—Pruritus—Dexamethasone—asthma	2.83e-05	0.00016	CcSEcCtD
Dihydroergotamine—Pruritus—Betamethasone—asthma	2.83e-05	0.00016	CcSEcCtD
Dihydroergotamine—Vomiting—Triamcinolone—asthma	2.8e-05	0.000158	CcSEcCtD
Dihydroergotamine—Vomiting—Methylprednisolone—asthma	2.79e-05	0.000158	CcSEcCtD
Dihydroergotamine—Nausea—Hydrocortisone—asthma	2.78e-05	0.000157	CcSEcCtD
Dihydroergotamine—Rash—Triamcinolone—asthma	2.78e-05	0.000157	CcSEcCtD
Dihydroergotamine—Dermatitis—Triamcinolone—asthma	2.77e-05	0.000157	CcSEcCtD
Dihydroergotamine—Rash—Methylprednisolone—asthma	2.77e-05	0.000157	CcSEcCtD
Dihydroergotamine—Dermatitis—Methylprednisolone—asthma	2.77e-05	0.000157	CcSEcCtD
Dihydroergotamine—Urticaria—Prednisone—asthma	2.76e-05	0.000156	CcSEcCtD
Dihydroergotamine—Headache—Triamcinolone—asthma	2.76e-05	0.000156	CcSEcCtD
Dihydroergotamine—Headache—Methylprednisolone—asthma	2.75e-05	0.000156	CcSEcCtD
Dihydroergotamine—Body temperature increased—Prednisone—asthma	2.75e-05	0.000156	CcSEcCtD
Dihydroergotamine—Abdominal pain—Prednisone—asthma	2.75e-05	0.000156	CcSEcCtD
Dihydroergotamine—Diarrhoea—Dexamethasone—asthma	2.73e-05	0.000155	CcSEcCtD
Dihydroergotamine—Diarrhoea—Betamethasone—asthma	2.73e-05	0.000155	CcSEcCtD
Dihydroergotamine—Dizziness—Betamethasone—asthma	2.64e-05	0.000149	CcSEcCtD
Dihydroergotamine—Dizziness—Dexamethasone—asthma	2.64e-05	0.000149	CcSEcCtD
Dihydroergotamine—Nausea—Triamcinolone—asthma	2.61e-05	0.000148	CcSEcCtD
Dihydroergotamine—Nausea—Methylprednisolone—asthma	2.61e-05	0.000148	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Prednisone—asthma	2.56e-05	0.000145	CcSEcCtD
Dihydroergotamine—Vomiting—Betamethasone—asthma	2.54e-05	0.000144	CcSEcCtD
Dihydroergotamine—Vomiting—Dexamethasone—asthma	2.54e-05	0.000144	CcSEcCtD
Dihydroergotamine—Rash—Dexamethasone—asthma	2.52e-05	0.000143	CcSEcCtD
Dihydroergotamine—Rash—Betamethasone—asthma	2.52e-05	0.000143	CcSEcCtD
Dihydroergotamine—Dermatitis—Betamethasone—asthma	2.52e-05	0.000142	CcSEcCtD
Dihydroergotamine—Dermatitis—Dexamethasone—asthma	2.52e-05	0.000142	CcSEcCtD
Dihydroergotamine—Headache—Dexamethasone—asthma	2.5e-05	0.000142	CcSEcCtD
Dihydroergotamine—Headache—Betamethasone—asthma	2.5e-05	0.000142	CcSEcCtD
Dihydroergotamine—Asthenia—Prednisone—asthma	2.5e-05	0.000141	CcSEcCtD
Dihydroergotamine—Pruritus—Prednisone—asthma	2.46e-05	0.000139	CcSEcCtD
Dihydroergotamine—Diarrhoea—Prednisone—asthma	2.38e-05	0.000135	CcSEcCtD
Dihydroergotamine—Nausea—Dexamethasone—asthma	2.37e-05	0.000134	CcSEcCtD
Dihydroergotamine—Nausea—Betamethasone—asthma	2.37e-05	0.000134	CcSEcCtD
Dihydroergotamine—Dizziness—Prednisone—asthma	2.3e-05	0.00013	CcSEcCtD
Dihydroergotamine—Vomiting—Prednisone—asthma	2.21e-05	0.000125	CcSEcCtD
Dihydroergotamine—Rash—Prednisone—asthma	2.19e-05	0.000124	CcSEcCtD
Dihydroergotamine—Dermatitis—Prednisone—asthma	2.19e-05	0.000124	CcSEcCtD
Dihydroergotamine—Headache—Prednisone—asthma	2.18e-05	0.000123	CcSEcCtD
Dihydroergotamine—Nausea—Prednisone—asthma	2.07e-05	0.000117	CcSEcCtD
Dihydroergotamine—HTR1D—Signaling by GPCR—IL2—asthma	8.15e-06	0.000103	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—IL2RA—asthma	8.15e-06	0.000103	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—C3—asthma	8.15e-06	0.000103	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ARG1—asthma	8.13e-06	0.000103	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—C3—asthma	8.09e-06	0.000102	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—ALOX5—asthma	8.07e-06	0.000102	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—CCL2—asthma	8.05e-06	0.000102	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—IL2RA—asthma	8.05e-06	0.000102	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—EDNRB—asthma	8.03e-06	0.000101	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—IL6R—asthma	8.03e-06	0.000101	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CXCL10—asthma	8.02e-06	0.000101	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—PDGFB—asthma	7.99e-06	0.000101	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—IL2—asthma	7.98e-06	0.000101	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—RHOA—asthma	7.98e-06	0.000101	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—C3—asthma	7.98e-06	0.000101	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NPS—asthma	7.95e-06	0.0001	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TAC1—asthma	7.95e-06	0.0001	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—PDGFB—asthma	7.93e-06	0.0001	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NTRK1—asthma	7.87e-06	9.93e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—CXCL8—asthma	7.85e-06	9.91e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—PPP2CA—asthma	7.81e-06	9.86e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CXCR3—asthma	7.8e-06	9.85e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—ADRB2—asthma	7.78e-06	9.83e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—PDGFB—asthma	7.76e-06	9.81e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CARM1—asthma	7.69e-06	9.72e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CCR5—asthma	7.67e-06	9.68e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—LEP—asthma	7.64e-06	9.65e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—LEP—asthma	7.58e-06	9.58e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—DCN—asthma	7.58e-06	9.58e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—IL2RA—asthma	7.56e-06	9.54e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CYBA—asthma	7.55e-06	9.54e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—IL2—asthma	7.5e-06	9.47e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—C3—asthma	7.49e-06	9.46e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—LEP—asthma	7.43e-06	9.38e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PARP1—asthma	7.39e-06	9.33e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IL5—asthma	7.39e-06	9.33e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—ALDH2—asthma	7.38e-06	9.32e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—ITPR1—asthma	7.36e-06	9.3e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ALDH7A1—asthma	7.36e-06	9.29e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—PDGFB—asthma	7.29e-06	9.21e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—RHOA—asthma	7.25e-06	9.16e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—FN1—asthma	7.21e-06	9.1e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—FN1—asthma	7.15e-06	9.03e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—BDKRB2—asthma	7.13e-06	9.01e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—POMC—asthma	7.12e-06	8.99e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—VEGFA—asthma	7.08e-06	8.94e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ARG2—asthma	7.05e-06	8.91e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—GSTP1—asthma	7.03e-06	8.88e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—GSTT1—asthma	7.02e-06	8.86e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CD86—asthma	7.01e-06	8.85e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—CXCL8—asthma	7.01e-06	8.85e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—FN1—asthma	7e-06	8.84e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—LEP—asthma	6.98e-06	8.81e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—EDN1—asthma	6.96e-06	8.79e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—HMOX1—asthma	6.94e-06	8.76e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—ITPR1—asthma	6.92e-06	8.74e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CCL5—asthma	6.9e-06	8.72e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—ADCY2—asthma	6.9e-06	8.71e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IL3—asthma	6.88e-06	8.68e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—PLA2G4A—asthma	6.88e-06	8.68e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—CAT—asthma	6.84e-06	8.64e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CSF2—asthma	6.8e-06	8.59e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—IL2—asthma	6.7e-06	8.46e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—SMAD3—asthma	6.62e-06	8.36e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—FN1—asthma	6.58e-06	8.31e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—POMC—asthma	6.57e-06	8.29e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—POMC—asthma	6.52e-06	8.23e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—TGFB1—asthma	6.5e-06	8.21e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—KNG1—asthma	6.49e-06	8.19e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—POMC—asthma	6.47e-06	8.17e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—GSTM1—asthma	6.46e-06	8.16e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—PLA2G4A—asthma	6.46e-06	8.16e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—AGTR1—asthma	6.45e-06	8.14e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CCL2—asthma	6.42e-06	8.11e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—IL6R—asthma	6.4e-06	8.09e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—POMC—asthma	6.38e-06	8.06e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CCL2—asthma	6.38e-06	8.05e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—CXCL8—asthma	6.36e-06	8.04e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—IL6R—asthma	6.36e-06	8.03e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—PPP2CA—asthma	6.33e-06	8e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CCL2—asthma	6.33e-06	7.99e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—IL6R—asthma	6.31e-06	7.97e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CXCL10—asthma	6.3e-06	7.96e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—EGFR—asthma	6.28e-06	7.94e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—RHOA—asthma	6.27e-06	7.92e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CCL2—asthma	6.24e-06	7.88e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—EGFR—asthma	6.24e-06	7.88e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—IL6R—asthma	6.22e-06	7.86e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CCR5—asthma	6.22e-06	7.85e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NTRK1—asthma	6.18e-06	7.81e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Transmembrane transport of small molecules—ALB—asthma	6.15e-06	7.77e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—IL2RA—asthma	6.13e-06	7.74e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—ADRB2—asthma	6.12e-06	7.73e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—EGFR—asthma	6.11e-06	7.71e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—IL2—asthma	6.08e-06	7.68e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—C3—asthma	6.08e-06	7.67e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—SERPINE1—asthma	6e-06	7.57e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—POMC—asthma	5.99e-06	7.57e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—PPP2CA—asthma	5.95e-06	7.52e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—SERPINE1—asthma	5.95e-06	7.52e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—PDGFB—asthma	5.91e-06	7.47e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CCL2—asthma	5.86e-06	7.41e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—IL6R—asthma	5.85e-06	7.38e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ALOX5AP—asthma	5.84e-06	7.38e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ALOX15—asthma	5.84e-06	7.38e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—NQO1—asthma	5.83e-06	7.36e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—SERPINE1—asthma	5.83e-06	7.36e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—ITPR1—asthma	5.79e-06	7.31e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—RHOA—asthma	5.79e-06	7.31e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—RHOA—asthma	5.74e-06	7.25e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—EGFR—asthma	5.74e-06	7.24e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NOS3—asthma	5.73e-06	7.23e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—ADCY2—asthma	5.71e-06	7.21e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—RHOA—asthma	5.7e-06	7.2e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NOS3—asthma	5.68e-06	7.18e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—LEP—asthma	5.66e-06	7.14e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—RHOA—asthma	5.62e-06	7.1e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CHAT—asthma	5.58e-06	7.04e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NOS3—asthma	5.56e-06	7.03e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CD86—asthma	5.51e-06	6.96e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—CXCL8—asthma	5.51e-06	6.96e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—SERPINE1—asthma	5.47e-06	6.91e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—EDN1—asthma	5.47e-06	6.9e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CCL5—asthma	5.43e-06	6.85e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PLA2G4A—asthma	5.4e-06	6.83e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CSF2—asthma	5.34e-06	6.75e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—FN1—asthma	5.34e-06	6.74e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—RHOA—asthma	5.28e-06	6.67e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—IL2—asthma	5.26e-06	6.65e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NOS3—asthma	5.23e-06	6.6e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—SMAD3—asthma	5.2e-06	6.57e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CXCL8—asthma	5.08e-06	6.41e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CXCL8—asthma	5.04e-06	6.37e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CXCL8—asthma	5e-06	6.32e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PPP2CA—asthma	4.98e-06	6.29e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ALOX5—asthma	4.97e-06	6.28e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CXCL8—asthma	4.94e-06	6.23e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CCR5—asthma	4.89e-06	6.17e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—GSTP1—asthma	4.86e-06	6.14e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—POMC—asthma	4.86e-06	6.14e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—IL2—asthma	4.85e-06	6.13e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—IL6—asthma	4.83e-06	6.1e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—IL2—asthma	4.82e-06	6.08e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IL2RA—asthma	4.82e-06	6.08e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—HMOX1—asthma	4.8e-06	6.06e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—IL6—asthma	4.79e-06	6.05e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—ITPR1—asthma	4.79e-06	6.04e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—IL2—asthma	4.78e-06	6.04e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—C3—asthma	4.78e-06	6.03e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CCL2—asthma	4.76e-06	6.01e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—IL6R—asthma	4.74e-06	5.99e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CARM1—asthma	4.74e-06	5.99e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CAT—asthma	4.73e-06	5.98e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—IL2—asthma	4.72e-06	5.96e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—IL6—asthma	4.69e-06	5.93e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—DCN—asthma	4.67e-06	5.9e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—EGFR—asthma	4.65e-06	5.87e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PDGFB—asthma	4.65e-06	5.87e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CXCL8—asthma	4.64e-06	5.85e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—MMP9—asthma	4.59e-06	5.8e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—POMC—asthma	4.57e-06	5.77e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—PTEN—asthma	4.57e-06	5.77e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—MMP9—asthma	4.56e-06	5.76e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ALDH2—asthma	4.54e-06	5.74e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—PTEN—asthma	4.53e-06	5.72e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—GSTM1—asthma	4.47e-06	5.64e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PLA2G4A—asthma	4.47e-06	5.64e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—MMP9—asthma	4.46e-06	5.64e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—LEP—asthma	4.45e-06	5.62e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—SERPINE1—asthma	4.44e-06	5.61e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—PTEN—asthma	4.44e-06	5.6e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—IL2—asthma	4.43e-06	5.6e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—IL6—asthma	4.41e-06	5.57e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GSTT1—asthma	4.32e-06	5.46e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—RHOA—asthma	4.28e-06	5.41e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NOS3—asthma	4.24e-06	5.35e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—MMP9—asthma	4.19e-06	5.3e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—FN1—asthma	4.19e-06	5.3e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—PTEN—asthma	4.17e-06	5.26e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—ALB—asthma	4.16e-06	5.26e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—VEGFA—asthma	4.13e-06	5.21e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PPP2CA—asthma	4.12e-06	5.2e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—VEGFA—asthma	4.09e-06	5.17e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—STAT3—asthma	4.08e-06	5.16e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—STAT3—asthma	4.05e-06	5.12e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—VEGFA—asthma	4.01e-06	5.06e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—NOS3—asthma	3.98e-06	5.03e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—STAT3—asthma	3.97e-06	5.01e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—POMC—asthma	3.82e-06	4.82e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TGFB1—asthma	3.79e-06	4.78e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—VEGFA—asthma	3.77e-06	4.76e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CXCL8—asthma	3.76e-06	4.75e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TGFB1—asthma	3.76e-06	4.75e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CCL2—asthma	3.74e-06	4.72e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—STAT3—asthma	3.73e-06	4.71e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IL6R—asthma	3.73e-06	4.71e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—EGFR—asthma	3.71e-06	4.69e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—EGFR—asthma	3.68e-06	4.65e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TGFB1—asthma	3.68e-06	4.65e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—EGFR—asthma	3.66e-06	4.62e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—PTGS2—asthma	3.64e-06	4.6e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—EGFR—asthma	3.61e-06	4.56e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—IL2—asthma	3.59e-06	4.54e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—NQO1—asthma	3.59e-06	4.54e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—IL6—asthma	3.58e-06	4.51e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ADCY2—asthma	3.52e-06	4.44e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—SERPINE1—asthma	3.49e-06	4.41e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TGFB1—asthma	3.46e-06	4.36e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—MMP9—asthma	3.4e-06	4.29e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—EGFR—asthma	3.39e-06	4.28e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—PTEN—asthma	3.38e-06	4.27e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—RHOA—asthma	3.37e-06	4.25e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NOS3—asthma	3.33e-06	4.21e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—PTEN—asthma	3.18e-06	4.01e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—POMC—asthma	3.16e-06	3.99e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—VEGFA—asthma	3.05e-06	3.86e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—STAT3—asthma	3.02e-06	3.82e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GSTP1—asthma	3e-06	3.78e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—HMOX1—asthma	2.96e-06	3.73e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CXCL8—asthma	2.95e-06	3.73e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ITPR1—asthma	2.95e-06	3.72e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CAT—asthma	2.92e-06	3.68e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—ALB—asthma	2.88e-06	3.64e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—IL6—asthma	2.85e-06	3.6e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—IL6—asthma	2.83e-06	3.58e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IL2—asthma	2.82e-06	3.57e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—IL6—asthma	2.81e-06	3.55e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TGFB1—asthma	2.8e-06	3.54e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—IL6—asthma	2.77e-06	3.5e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—NOS3—asthma	2.75e-06	3.48e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PLA2G4A—asthma	2.75e-06	3.48e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GSTM1—asthma	2.75e-06	3.48e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—EGFR—asthma	2.75e-06	3.47e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—MMP9—asthma	2.67e-06	3.38e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PTEN—asthma	2.66e-06	3.36e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—IL6—asthma	2.6e-06	3.29e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PPP2CA—asthma	2.54e-06	3.2e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PTGS2—asthma	2.52e-06	3.18e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—VEGFA—asthma	2.4e-06	3.03e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—STAT3—asthma	2.38e-06	3e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TGFB1—asthma	2.2e-06	2.78e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PTEN—asthma	2.2e-06	2.78e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—EGFR—asthma	2.16e-06	2.73e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—IL6—asthma	2.11e-06	2.67e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—POMC—asthma	1.95e-06	2.46e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ALB—asthma	1.77e-06	2.24e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—NOS3—asthma	1.7e-06	2.14e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IL6—asthma	1.66e-06	2.1e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PTGS2—asthma	1.55e-06	1.96e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PTEN—asthma	1.35e-06	1.71e-05	CbGpPWpGaD
